论文部分内容阅读
微小残留白血病（Ｍｉｎｉｍａｌ Ｒｅｓｉｄｕａｌ Ｌｅｕｋｅｍｉａ， ＭＲＬ）是指白血病患者经过现代化疗（包括骨髓移植）后按目前确定的疗效标准取得完全缓解（ＣＲ）后体内残留微量白血病细胞的状态。许多研究表明，白血病的复发来自原发时的白血病细胞的恶性克隆。因此
Minimal Residual Leukemia (MRL) refers to the state of residual leukemic cells in patients with leukemia after complete remission (CR) according to the currently established standard of efficacy after modern chemotherapy (including bone marrow transplantation). Many studies have shown that the recurrence of leukemia comes from malignant cloning of leukemia cells in primary cells. therefore